Drawing for PROTEOONE

USPTO serial 79337696

PROTEOONE

Reviewed by CopyMark Law Group

Reg. 6998551Status 700Registered
Filing date
Status date
Registration date
Mar 14, 2023
Examiner
SHINER, MARK W
Law office
Historical data usage

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with PROTEOONE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

DAVID M. TENER

DAVID M. TENER Caesar Rivise, PC500 Office Center DriveSuite 400Fort Washington, PA 19034

Goods and services

ClassDescriptionStatusFirst use
009Biochips for research or scientific purposes; bioreactor for cell culturing; bioreactors for laboratory use; bioreactors for medical research use; cell culture apparatus for laboratory use, namely, cell culture dishes; laboratory devices for analyzing genome information; devices for analyzing protein sequence used as laboratory apparatus; DNA chips; DNA microarray; non-medical imaging devices for mammalian cells, bacterial cells, spore cells, particles, and cell aggregates in the nature of clusters of cells, spheroids and organoids for scientific purposes; non-medical immunostaining instruments for scientific purposes; non-medical incubation plates for scientific or laboratory use; incubators for laboratory use; non-medical diagnostic instruments for DNA analysis for scientific research use, not for medical use; laboratory apparatus and instruments for extracting DNA; laboratory incubators other than for medical use; laboratory instruments in the nature of cell sorter, flow cytometer, cell isolator, cell counter and liquid dispensers in the nature of a glass capillary surrounded by a piezo ceramic connected to a syringe pump other than for medical use; laboratory optical apparatus, namely, optical mirrors; LED microscopes; non-medical lasers for scientific use; lenses for microscopes; microarray slides for laboratory use; microplate readers; microscope slides being laboratory equipment; glassware models for scientific experiments in laboratories; nucleic acid sequencers for scientific purposes; petri dishes; petri dishes used in laboratory research; pipette tips for laboratory pipettes; laboratory pipettes; scientific distillation apparatus and instruments; print heads for inkjet document printers; disposable plastic bioreactors for cell culture; bioreactors for cell culture; laboratory apparatus for fabrication of three-dimensional tissues and organs; scientific research and laboratory apparatus and instruments in the nature of cell sorters, flow cytometers, cell isolators, cell counters and liquid dispensers in the nature of a glass capillary surrounded by a piezo ceramic connected to a syringe pump in the field of cytology; equipment for scientific research and laboratory apparatus and instruments in the name of cell sorters, flow cytometers, cell isolators, cell counters, liquid dispensers in the nature of a glass capillary surrounded by a piezo ceramic connected to a syringe pump in the field of cytology; scientific research and laboratory apparatus, namely, cell handling apparatus in the nature of petri dishes, cell analysis and cell separation apparatus in the nature of flow cytometers and flow-based analyzers providing cell and particle analysis, detection, or counting; scientific research and laboratory apparatus, namely, cell culture apparatus in the nature of petri dishes for laboratory use; laboratory apparatus and instruments in the nature of biochips for use in biopharmaceutical discovery and development for research or scientific purposes; laboratory apparatus and instruments in the nature of biochips for use in cell detection and molecular discovery for research or scientific purposes; laboratory apparatus and instruments for the analysis, retrieval or discovery of single cells; laboratory apparatus and instruments for use in assuring monoclonality; replacement and structural parts and fittings for all the aforesaid goods; laboratory apparatus for fabrication of three dimensional (3D) living tissues; laboratory equipment for scientific and research use, namely, systems comprised of fluid dispenser, imaging station, computer hardware, recorded control software, recorded software for analysis, chips and reagentsACTIVE—
010[ Tools, namely, medical apparatus and instruments, for medical diagnostics of cancer, autoimmune disease, heart disease, brain disease, respiratory disease; diagnostic apparatus for use in the diagnosis of cancer, autoimmune disease, heart disease, brain disease, liver disease, respiratory disease for medical purposes; diagnostic instruments for use in the diagnosis of cancer, autoimmune disease, heart disease, brain disease, liver disease, respiratory disease for medical use; testing probes for medical diagnostic purposes, diagnostic imaging apparatus for medical use; optical imaging apparatus for medical diagnostic use; membrane test plates for use in medical diagnostics; apparatus for carrying out diagnostic tests of cancer, autoimmune disease, heart disease, brain disease, liver disease, respiratory disease and for prenatal testing for medical purposes; cell culture instruments for medical use, namely, cell culture chambers; inkjet based medical devices for use in medical research and genetic research and in the medical fields where molecular or cell separations is needed; medical diagnostic testing apparatus in the nature of cell sorters, flow cytometers, cell isolators, cell counters, liquid dispensers for use in immuno-assay procedures; medical diagnostic testing instruments in the nature of cell sorters, flow cytometers, cell isolators, cell counters, liquid dispensers for immunoassay procedures; medical apparatus and instruments in the fields of cytology, namely, cell sorters, flow cytometers, cell isolators, cell counters, liquid dispensers ]SECTION 7(e) - CANCELLED—
042[ Biological research, scientific clinical research and medical research; biomedical research services; scientific clinical research; development of pharmaceutical preparations and medicines; laboratory research services relating to pharmaceuticals; laboratory research services relating to dermatology; laboratory research services relating to the production of monoclonal antibodies; medical laboratory services; medical research; pharmaceutical drug development services; pharmaceutical product evaluation; pharmaceutical products development; pharmaceutical research and development; pharmaceutical research services; scientific research and development for the pharmaceutical industry; research and development in the pharmaceutical and biotechnology fields; research and development of vaccines and medicines; scientific research and development; scientific research for medical purposes in the area of cancerous diseases; scientific research in the field of pharmacy; services in the nature of pharmaceutical production, namely, development of pharmaceutical preparations; evaluation for assessing the efficiency of pharmaceuticals; services in the nature of product quality evaluation for assessing the efficiency of veterinary drugs; testing of pharmaceuticals; research and development services in the field of antibodies; research and development in the field of microorganisms and cells; scientific laboratory services relating to the isolation and cultivation of human tissues and cells; medical research relating to medicine; medical research relating to medicines; design and development of diagnostic apparatus; design of diagnostic apparatus and equipment; design and development of medical diagnostic apparatus; research and development in the field of diagnostic preparations; research and development services in the field of cytology; biotechnology research; biotechnology testing for scientific research purposes; research and development in the field of biotechnology; research relating to biotechnology; consultancy relating to biotechnology; consultancy in the field of biotechnology; scientific and medical research and development in the field of cytology; scientific and medical research and development in the field of bioprinting ]SECTION 7(e) - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jun 16, 2026NURCNOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED—
May 23, 2026LIMELIMITATION FROM THE IB EXAMINED AND ENTERED—
May 22, 2026COC.CORRECTION UNDER SECTION 7 - PROCESSED—
May 22, 2026APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Mar 23, 2026TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Mar 23, 2026ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS—
Mar 23, 2026ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 23, 2026REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Apr 4, 2025LIMGLIMITATION OF GOODS RECEIVED FROM IB—
Aug 19, 2023NREPNEW REPRESENTATIVE AT IB RECEIVED—
Jul 22, 2023FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Jun 27, 2023FICSFINAL DISPOSITION NOTICE SENT TO IB—
Jun 27, 2023FIMPFINAL DISPOSITION PROCESSED—
Jun 14, 2023FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Mar 14, 2023NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Mar 14, 2023R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Dec 27, 2022NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Dec 27, 2022PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 7, 2022NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Nov 18, 2022CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Oct 24, 2022TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Oct 24, 2022CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 24, 2022TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 2, 2022RFNTREFUSAL PROCESSED BY IB—
Jul 12, 2022RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Jul 12, 2022RFRRREFUSAL PROCESSED BY MPU—
Jul 7, 2022RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Jul 6, 2022CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 29, 2022DOCKASSIGNED TO EXAMINER—
Apr 12, 2022MAFRAPPLICATION FILING RECEIPT MAILED—
Apr 8, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Apr 7, 2022REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance